Wayne Winegarden
Commentary
Requiring That Drug Advertisements Include List Prices Promotes Misinformation
The largest problems in the health care industry are often created by reformers envisioning themselves as free market saviors, when in reality they are merely advocates for more intrusive government regulations. The Trump administration’s proposal to require that drug advertisements include the medicine’s list price is such an example. On its face, ...
Wayne Winegarden
October 17, 2018
Commentary
Free-market Environmentalism
Many of you may be unaware, but this past week was National Clean Energy Week. And, while many economically harmful policies have been proposed in pursuit of clean, efficient, and cost-effective renewable energy, the goal is worthwhile. It just matters how we get there. The Clean Capitalist Coalition (full disclosure, I participate in ...
Wayne Winegarden
September 28, 2018
Blog
Why the Two Orders? Freezing CAFE standards was the correct policy
The Environmental Protection Agency (EPA) has proposed freezing CAFE standards at the 2020 levels of 37 mpg. While a bit of a non sequitur, this freeze is reminiscent of the climactic scene from the 1992 film A Few Good Men. For those of you who missed the movie, or just ...
Wayne Winegarden
September 24, 2018
Business & Economics
The Opportunity Created by California’s Overly-Generous Public Pensions
Americans are facing two very different pension outlooks. Most private sector workers contribute to 401(k) plans (which are often matched by employers), and rely on investments, savings, and Social Security for their retirement. But, their savings is inadequate. According to a 2018 survey by Northwestern Mutual, 33 percent of Baby Boomers ...
Wayne Winegarden
September 20, 2018
Business & Economics
CAFE Standards versus Public Opinion
Calls for stricter environmental mandates contradict the broad public consensus on global warming. According to a 2018 report by the Yale Program on Climate Change Communication, seven out of ten Americans believe global warming is happening and six out of ten say they are at least “somewhat worried”. Other polls differ ...
Wayne Winegarden
September 18, 2018
Business & Economics
Eliminate Pharmaceutical Rebates to Improve Patient Welfare
Pfizer CEO Ian Read recently told investors that he believes pharmaceuticals will soon be sold without rebates. While this change, if it comes to pass, is undoubtedly positive for patients, a question naturally arises: why? After all, rebates and discounts are a normal part of most competitive markets. The problem ...
Wayne Winegarden
August 16, 2018
Business & Economics
Reforming Medicare’s Competitive Bidding Program To Improve Health And Lower Costs
Through its purchases of durable medical equipment (DME), the Centers for Medicare & Medicaid Services’ (CMS) helps many patients remain in their home and out of hospitals or other long-term care settings. These purchases cover a wide array of medical equipment including diabetes testing strips, wheelchairs, and oxygen tanks. Previously, ...
Wayne Winegarden
August 7, 2018
Blog
California’s Public Pension Systems Are Not Immune from Financial Consequences
Step one in any recovery program is to admit that the problem exists. And, make no mistake about it, California’s public pensions are addicted to debt. Solving this debt crisis requires political courage to implement fundamental reforms, which is why studies that provide excuses not to act are so troubling. ...
Wayne Winegarden
July 31, 2018
Health Care
NEW STUDY: Medicare Competitive Bidding Process Should Be Reformed
Proposed reforms to the Medicare competitive bidding process for wheelchairs, home breathing equipment, and other durable medical equipment underscore the findings of a recently-released Pacific Research Institute study showing that patient health is being negatively impacted by an inefficient system plagued by low provider payments and lack of access to ...
Wayne Winegarden
July 26, 2018
Business & Economics
It’s Generics Not PBMs That Keep Pharmaceuticals Affordable
Expenditures on prescription drugs grew 12.4 percent in 2014 and 8.9 percent in 2015. These eye-popping data are not representative of the long-term expenditure trend, however. Not only did the growth in prescription drugs expenditures slow to 1.3 percent in 2016, longer-term (between 2009 and 2016), the average annual growth ...
Wayne Winegarden
July 12, 2018
Requiring That Drug Advertisements Include List Prices Promotes Misinformation
The largest problems in the health care industry are often created by reformers envisioning themselves as free market saviors, when in reality they are merely advocates for more intrusive government regulations. The Trump administration’s proposal to require that drug advertisements include the medicine’s list price is such an example. On its face, ...
Free-market Environmentalism
Many of you may be unaware, but this past week was National Clean Energy Week. And, while many economically harmful policies have been proposed in pursuit of clean, efficient, and cost-effective renewable energy, the goal is worthwhile. It just matters how we get there. The Clean Capitalist Coalition (full disclosure, I participate in ...
Why the Two Orders? Freezing CAFE standards was the correct policy
The Environmental Protection Agency (EPA) has proposed freezing CAFE standards at the 2020 levels of 37 mpg. While a bit of a non sequitur, this freeze is reminiscent of the climactic scene from the 1992 film A Few Good Men. For those of you who missed the movie, or just ...
The Opportunity Created by California’s Overly-Generous Public Pensions
Americans are facing two very different pension outlooks. Most private sector workers contribute to 401(k) plans (which are often matched by employers), and rely on investments, savings, and Social Security for their retirement. But, their savings is inadequate. According to a 2018 survey by Northwestern Mutual, 33 percent of Baby Boomers ...
CAFE Standards versus Public Opinion
Calls for stricter environmental mandates contradict the broad public consensus on global warming. According to a 2018 report by the Yale Program on Climate Change Communication, seven out of ten Americans believe global warming is happening and six out of ten say they are at least “somewhat worried”. Other polls differ ...
Eliminate Pharmaceutical Rebates to Improve Patient Welfare
Pfizer CEO Ian Read recently told investors that he believes pharmaceuticals will soon be sold without rebates. While this change, if it comes to pass, is undoubtedly positive for patients, a question naturally arises: why? After all, rebates and discounts are a normal part of most competitive markets. The problem ...
Reforming Medicare’s Competitive Bidding Program To Improve Health And Lower Costs
Through its purchases of durable medical equipment (DME), the Centers for Medicare & Medicaid Services’ (CMS) helps many patients remain in their home and out of hospitals or other long-term care settings. These purchases cover a wide array of medical equipment including diabetes testing strips, wheelchairs, and oxygen tanks. Previously, ...
California’s Public Pension Systems Are Not Immune from Financial Consequences
Step one in any recovery program is to admit that the problem exists. And, make no mistake about it, California’s public pensions are addicted to debt. Solving this debt crisis requires political courage to implement fundamental reforms, which is why studies that provide excuses not to act are so troubling. ...
NEW STUDY: Medicare Competitive Bidding Process Should Be Reformed
Proposed reforms to the Medicare competitive bidding process for wheelchairs, home breathing equipment, and other durable medical equipment underscore the findings of a recently-released Pacific Research Institute study showing that patient health is being negatively impacted by an inefficient system plagued by low provider payments and lack of access to ...
It’s Generics Not PBMs That Keep Pharmaceuticals Affordable
Expenditures on prescription drugs grew 12.4 percent in 2014 and 8.9 percent in 2015. These eye-popping data are not representative of the long-term expenditure trend, however. Not only did the growth in prescription drugs expenditures slow to 1.3 percent in 2016, longer-term (between 2009 and 2016), the average annual growth ...